Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06303193
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-03-08
Brief Title:
Pacritinib a Kinase Inhibitor of CSF1R IRAK1 JAK2 and FLT3 in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or MyelodysplasticMyeloproliferative Neoplasms
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndromes |